Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
The OnDemand version of this program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

SESSION 1 - LEARNING OBJECTIVES

• Explore the importance of ejection fraction in the management of heart failure
• Describe appropriate management strategies and therapies for heart failure in 2023
• Recognize the role of newer treatments to improve outcomes for patients with chronic kidney disease
• Examine the appropriate use of medication to support patients with obesity

SESSION 2 - LEARNING OBJECTIVES

• Identify the long-term impact of PCSK9 inhibitors on CV mortality
• Define the role of inclisaran in lipd management
• Descirbe when and how to use Lp(a) for risk assessment
• Describe the role of inflammation on CV outcomes and management options

The OnDemand recordings of this live program are NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from Amgen and Boehringer Ingelheim 

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program is available for CCRN members of the CCRN website. Visit www.ccrnmd.com/resources to download the materials.